| SYNTHESIS |
According to Ian C. Lennon, technology leader of pharmaceutical services from Dow, hydrogenation of dimethyl itaconate with the rhodium complex of this ligand at a molar substrate-to-catalyst ratio of 100,000 yields a product with an enantiomeric excess of 99%. |
| UPDATE | 02.03 |
| COMPANY | Dow Pharma Services |
| LITERATURE REF. | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |